US 7074410
Modified HCV peptide vaccines
granted A61KA61K2039/53A61K2039/55522
Quick answer
US patent 7074410 (Modified HCV peptide vaccines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jul 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/53, A61K2039/55522, A61K2039/55538, A61K2039/55566